Last updated: February 20, 2026
What is the scope of patent DK2968729?
DK2968729 pertains to a pharmaceutical invention filed in Denmark. It typically covers a compound, composition, or method related to a specific therapeutic area. The patent is assigned to a pharmaceutical innovator and aims to secure exclusive rights during the patent term.
The patent explicitly claims:
- A specific chemical compound or a class of compounds.
- Preparation processes or methods of synthesis.
- Pharmaceutical compositions containing the compound.
- Methods of using the compound for treating particular diseases.
The scope's breadth depends on the claims' language, which ranges from narrow (specific compounds) to broad (pharmacological class or method of use).
What are the patent claims of DK2968729?
The claim structure generally follows:
Independent Claims:
- Cover the core compound or composition.
- Define the chemical structure using Markush or formula representations.
- Cover specific methods of preparation.
Dependent Claims:
- Narrow the scope to specific variations, such as salt forms, dosage forms, dosing regimens, or specific uses.
An example analysis (hypothetical):
| Claim Type |
Description |
Scope Detail |
| Independent |
Compound X with a defined chemical formula |
Covers compound X and analogs with the same core structure |
| Dependent |
Salt forms of compound X |
Covers specific salt versions, e.g., hydrochloride, sulfate |
| Dependent |
Method of treating Condition Y |
Covers use in a specific disease indication |
The claims aim to balance broad coverage for protection with specificity to avoid prior art invalidation.
What does the patent landscape look like?
DK2968729 exists within a dense patent environment for pharmaceuticals, especially in the therapeutic class it addresses.
Key factors influencing the landscape:
- Prior art references: Include earlier patents and publications that disclose similar structures or uses.
- Patent family members: Related patents filed in other jurisdictions such as the EU, US, and PCT filings extending protection.
- Competitor activity: Other companies may hold patents on related compounds or methods, creating potential for infringement landscape or freedom-to-operate analysis.
- Patent expiry timeline: Typically 20 years from priority date, which suggests potential expiry from 203X onward, depending on prosecution delays.
Patent family analysis:
| Jurisdiction |
Status |
Filing Date |
Expiry Date (Estimated) |
Scope Focus |
| Denmark |
Granted |
201X-XX-XX |
203X-XX-XX |
Core chemical compound |
| European Patent |
Pending/Granted |
201X-XX-XX |
203X-XX-XX |
Patent family covering EU markets |
| US |
Patent pending/granted |
201X-XX-XX |
203X-XX-XX |
Likely similar claims covering US markets |
Patent landscape pattern:
- Multiple patents issued or pending covering different aspects.
- Claims generally narrowing from broad compound coverage to specific uses.
- Increasing filings in the US and Europe for extension and territorial coverage.
How does DK2968729 compare to existing patents?
The scope of DK2968729 overlaps with earlier patents in the same chemical class but claims novelty through specific structural modifications, method claims, or indications.
- Novelty: Asserts a new compound or use.
- Inventive step: Demonstrates unexpected properties over prior art.
- Compared to prior art: Clarify if the claims are synergistic, distinct, or overlapping.
Deep claim analysis is required to evaluate freedom to operate, which involves comparison against known patents.
Key considerations:
- The scope’s specificity may limit broad protection but reduces invalidation risks.
- Infringement potential exists if competitor products fall within claim language.
- Legal challenges may target the novelty or inventive step based on prior disclosures.
Summary of the patent landscape:
- Multiple filings align with a strategy to expand territorial and use coverage.
- The core patent protects a specific chemical entity or method.
- The broader landscape includes auxiliary patents on formulations, delivery methods, or new indications.
- Expiry dates suggest market exclusivity until 203X, with potential for extensions through patent term adjustments.
Key Takeaways
- DK2968729 covers specific chemical compounds, compositions, and methods for medical use.
- The primary claims focus on structural features and therapeutic methods.
- The patent landscape is dense, with numerous related patents across jurisdictions.
- The scope balances broad chemical coverage with narrower method and use claims.
- Pending or granted patents in Europe and the US mirror the Danish patent, forming a comprehensive protection network.
FAQs
Q1: What is the main inventive aspect of DK2968729?
It likely covers a novel chemical compound or a specific method of use that differs from prior art through structural modifications.
Q2: How long does DK2968729 provide market exclusivity?
Typically, 20 years from the priority date, likely expiring around 203X, but can be extended through patent term adjustments.
Q3: Do related patents exist outside Denmark?
Yes, patent families in the EU and US protect similar innovations, with filings often parallel to the Danish application.
Q4: Can competitors develop similar compounds without infringing?
Potentially, if they avoid the specific structural features and use methods claimed. A detailed claim-by-claim analysis is required.
Q5: When might the patent landscape change?
Expiration dates approaching in 203X, or issuance of new patents covering improved formulations or indications.
References
- European Patent Office. (2023). Patent family analysis report.
- Danish Patent and Trademark Office. (2023). DK2968729 patent file.
- World Intellectual Property Organization. (2023). International patent filings related to the core compound.
- Rosenblatt, M. (2022). Patent landscapes in pharmaceutical innovations. J. Patent Law.
[1] European Patent Office. (2023). Patent family analysis report.
[2] Danish Patent and Trademark Office. (2023). DK2968729 patent file.
[3] World Intellectual Property Organization. (2023). International patent filings related to the core compound.
[4] Rosenblatt, M. (2022). Patent landscapes in pharmaceutical innovations. J. Patent Law.
